Blonde L, Belousova L, Fainberg U, et al
The website will direct patients to drugmakers direct-to-consumer platforms, where some of their products will be available at a discount for cash-paying patients, say, in the deductible phase of their insurance, or those who are not insured (either no health insurance at all, or not insured for obesity medicines)
This information helps your provider decide whether to maintain the current dose or begin dose escalation at the next scheduled adjustment
Overdosing wastes peptide faster than necessary
Key Takeaways Starting dose: 2 mg once weekly for 4 weeks Titration pace: Increase every 4 weeks: 2 4 8 12 mg Maximum dose: 12 mg weekly (Phase 2/3 clinical trial protocol) Total ramp-up: ~16 weeks to reach maximum dose Mechanism: Triple agonist (GLP-1 + GIP + Glucagon), the only triple-agonist in late-stage trials Weight loss: Up to 24.2% at 48 weeks (Phase 2) and 28.7% at 68 weeks (Phase 3 TRIUMPH-4) GLP-3 Retatrutide Dosage Chart Free printable reference chart showing the retatrutide (GLP-3) clinical trial titration schedule from 2 mg to 12 mg weekly
This not only makes us shorter, but also loosens the rubber bands (ligaments) along the spine